Physical activity, sex steroid, and growth factor concentrations in pre- and post-menopausal women: A cross-sectional study within the EPIC cohort

Cancer Causes and Control

Volumn 25, Issue 1, 2014, Pages 111-124

  Rinaldi, S ^a   Kaaks, R ^b   Friedenreich, C M ^c   Key, T J ^d   Travis, R ^d   Biessy, C ^a   Slimani, N ^a   Overvad, K ^e,f   Ostergaard J N ^e,f   Tjonneland A ^g   Olsen, A ^g   Mesrine, S ^h,i,j   Fournier, A ^h,i,j   Dossus, L ^h,i,j   Lukanova, A ^b,k   Johnson, T ^b   Boeing, H ^l   Vigl, M ^l   Trichopoulou, A ^m,n   Benetou, V ^m   Trichopoulos, D ^m,n,o   Masala, G ^p   Krogh, V ^q   Tumino, R ^r   Ricceri, F ^s   Panico, S ^t   Bueno De Mesquita, H B ^u,v,w   Monninkhof, E M ^v   May, A M ^v   Weiderpass, E ^x,y,z,aa   Quiros J R ^ab   Travier, N ^ac   Molina Montes, E ^ad,ae   Amiano, P ^ae,af   Huerta, J M ^ae,ag   Ardanaz, E ^ae,ah   Sund, M ^k   Johansson, M ^a,k   Khaw, K T ^ai   Wareham, N ^aj   Scalbert, A ^a   Gunter, M J ^w   Riboli, E ^w   Romieu, I ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c ALBERTA HEALTH SERVICES   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e AARHUS UNIVERSITY   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^h CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j INSTITUT GUSTAVE ROUSSY   (France)

^k UMEÅ UNIVERSITY   (Sweden)

^l GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^m UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁿ HELLENIC HEALTH FOUNDATION   (Greece)

^o BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^p CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^q NATIONAL CANCER INSTITUTE   (Italy)

^r Civile MP Arezzo Hospital   (Italy)

^s Human Genetics Foundation   (Italy)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^v UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^w IMPERIAL COLLEGE LONDON   (United Kingdom)

^x UNIVERSITY OF TROMSØ   (Norway)

^y KAROLINSKA INSTITUTE   (Sweden)

^z CANCER REGISTRY OF NORWAY   (Norway)

^aa FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ab PUBLIC HEALTH DIRECTORATE   (Spain)

^ac CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ad ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ae CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^af BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^ag DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^ah INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^ai UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aj MRC EPIDEMIOLOGY UNIT   (United Kingdom)

more..

Author keywords

Cross sectional; European Prospective Investigation into Cancer and nutrition (EPIC); Growth factors; Physical activity; Sex steroids

Indexed keywords

ANDROSTENEDIONE; GROWTH FACTOR; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; STEROID; TESTOSTERONE; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; BODY MASS; BODY SIZE; CALORIC INTAKE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GEOMETRY; HUMAN; LIFESTYLE; MALE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STEROID BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; EUROPE; MIDDLE AGED; MOTOR ACTIVITY; NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RISK;

ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; GONADAL STEROID HORMONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEOPLASMS; POSTMENOPAUSE; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK;

EID: 84893673037     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0314-x     Document Type: Article

References (64)

1. Friedenreich CM (2011) Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 188:125-139
2. Kaaks R, Rinaldi S, Key TJ et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071-1082
3. Key T, Appleby P, Reeves G, Endogenous Hormones and Breast Cancer Collaborative Group (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616
4. Kaaks R, Berrino F, Key T et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755-765
5. Eliassen AH, Missmer SA, Tworoger SS et al (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406-1415
6. Rinaldi S, Peeters PH, Berrino F et al (2006) IGF-I, IGFBP-3 and breast cancer risk in women: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13:593-605
7. Key TJ, Appleby PN, Reeves GK, Roddam AW (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530-542
8. Allen NE, Key TJ, Dossus L et al (2008) Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 15:485-497
9. Lukanova A, Lundin E, Micheli A et al (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425-432
10. Rinaldi S, Cleveland R, Norat T et al (2010) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126:1702-1715
11. van Gils CH, Peeters PH, Schoenmakers MC et al (2009) Physical activity and endogenous sex hormone levels in postmenopausal women: a cross-sectional study in the Prospect-EPIC Cohort. Cancer Epidemiol Biomarkers Prev 18:377-383
12. Bertone-Johnson ER, Tworoger SS, Hankinson SE (2009) Recreational physical activity and steroid hormone levels in postmenopausal women. Am J Epidemiol 170:1095-1104
13. McTiernan A, Wu L, Chen C et al (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) 14:1662-1677
14. McTiernan A, Tworoger SS, Rajan KB et al (2004) Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 13:1099-1105
15. McTiernan A, Tworoger SS, Ulrich CM et al (2004) Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 64:2923-2928
16. Liedtke S, Schmidt ME, Becker S et al (2011) Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI? Cancer Causes Control 22:81-89
17. Chan MF, Dowsett M, Folkerd E et al (2007) Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study. Cancer Epidemiol Biomarkers Prev 16:900-905
18. Friedenreich CM, Woolcott CG, McTiernan A et al (2010) Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol 28:1458-1466
19. De Cree C (1998) Sex steroid metabolism and menstrual irregularities in the exercising female. A review. Sports Med 25:369-406
20. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ (2001) Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 12:47-59
21. Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones. Cancer Causes Control 18:743-752
22. Kossman DA, Williams NI, Domchek SM, Kurzer MS, Stopfer JE, Schmitz KH (2011) Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J Appl Physiol 111:1687-1693
23. Sillanpaa E, Hakkinen A, Laaksonen DE, Karavirta L, Kraemer WJ, Hakkinen K (2010) Serum basal hormone concentrations, nutrition and physical fitness during strength and/or endurance training in 39-64-year-old women. Int J Sports Med 31:110-117
24. Allen NE, Appleby PN, Kaaks R, Rinaldi S, Davey GK, Key TJ (2003) Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women. Cancer Causes Control 14:65-74
25. Lukanova A, Toniolo P, Akhmedkhanov A et al (2001) A cross-sectional study of IGF-I determinants in women. Eur J Cancer Prev 10:443-452
26. Voskuil DW, Bueno de Mesquita HB, Kaaks R et al (2001) Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in premenopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12:951-958
27. Madigan MP, Troisi R, Potischman N, Dorgan JF, Brinton LA, Hoover RN (1998) Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes Control 9:199-207
28. Key TJ, Appleby PN, Reeves GK et al (2011) Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105:709-722
29. Riboli E, Hunt KJ, Slimani N et al (2002) European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113-1124
30. Bingham S, Riboli E (2004) Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206-215
31. Peeters PH, Lukanova A, Allen N et al (2007) Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14:81-90
32. Rinaldi S, Dossus L, Lukanova A et al (2007) Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 16:23-29
33. Haftenberger M, Schuit AJ, Tormo MJ et al (2002) Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1163-1176
34. Friedenreich C, Norat T, Steindorf K et al (2006) Physical activity and risk of colon and rectal cancers: the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15:2398-2407
35. Cust AE, Smith BJ, Chau J et al (2008) Validity and repeatability of the EPIC physical activity questionnaire: a validation study using accelerometers as an objective measure. Int J Behav Nutr Phys Act 5:33
36. Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498-S504
37. Lahmann PH, Friedenreich C, Schuit AJ et al (2007) Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16:36-42
38. Wareham NJ, Jakes RW, Rennie KL et al (2003) Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 6:407-413
39. Lynch BM, Neilson HK, Friedenreich CM (2011) Physical activity and breast cancer prevention. Recent Results Cancer Res 186:13-42
40. Centers for Disease Control and Prevention (1996) Physical activity and health
41. Friedenreich CM (2010) The role of physical activity in breast cancer etiology. Semin Oncol 37:297-302
42. Manson JE, Greenland P, LaCroix AZ et al (2002) Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 347:716-725
43. Brown WJ, Burton NW, Rowan PJ (2007) Updating the evidence on physical activity and health in women. Am J Prev Med 33:404-411
44. Rinaldi S, Dechaud H, Biessy C et al (2001) Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomarkers Prev 10:757-765
45. Rinaldi S, Geay A, Dechaud H et al (2002) Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 11:1065-1071
46. Greene JW (1993) Exercise-induced menstrual irregularities. Compr Ther 19:116-120
47. Smith AJ, Phipps WR, Arikawa AY et al (2011) Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women. Cancer Epidemiol Biomarkers Prev 20:1098-1106
48. Nagata C, Kaneda N, Kabuto M, Shimizu H (1997) Factors associated with serum levels of estradiol and sex hormone-binding globulin among premenopausal Japanese women. Environ Health Perspect 105:994-997
49. De Souza MJ, Toombs RJ, Scheid JL, O'Donnell E, West SL, Williams NI (2010) High prevalence of subtle and severe menstrual disturbances in exercising women: confirmation using daily hormone measures. Hum Reprod 25:491-503
50. Yanovski JA, Yanovski SZ, Boyle AJ et al (2000) Hypothalamic-pituitary- adrenal axis activity during exercise in African American and Caucasian women. J Clin Endocrinol Metab 85:2660-2663
51. Toniolo P, Koenig KL, Pasternack BS et al (1994) Reliability of measurements of total, protein-bound, and unbound estradiol in serum. Cancer Epidemiol Biomarkers Prev 3:47-50
52. Muti P, Trevisan M, Micheli A et al (1996) Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 5:917-922
53. Michaud DS, Manson JE, Spiegelman D et al (1999) Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 8:1059-1064
54. Dossus L, Kaaks R (2008) Nutrition, metabolic factors and cancer risk. Best Pract Res Clin Endocrinol Metab 22:551-571
55. Gibney J, Healy ML, Sonksen PH (2007) The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocr Rev 28:603-624
56. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G et al (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351-357
57. Monninkhof EM, Velthuis MJ, Peeters PH, Twisk JW, Schuit AJ (2009) Effect of exercise on postmenopausal sex hormone levels and role of body fat: a randomized controlled trial. J Clin Oncol 27:4492-4499
58. Friedenreich CM, Neilson HK, Woolcott CG et al (2011) Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer 18:357-369
59. Friedenreich CM, Cust AE (2008) Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. Br J Sports Med 42:636-647
60. Friedenreich CM, Neilson HK, Woolcott CG et al (2011) Mediators and moderators of the effects of a year-long exercise intervention on endogenous sex hormones in postmenopausal women. Cancer Causes Control 22:1365-1373
61. Lukanova A, Zeleniuch-Jacquotte A, Lundin E et al (2004) Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262-268
62. Pols MA, Peeters PH, Kemper HC, Collette HJ (1996) Repeatability and relative validity of two physical activity questionnaires in elderly women. Med Sci Sports Exerc 28:1020-1025
63. Pols MA, Peeters PH, Ocke MC, Slimani N, Bueno-de-Mesquita HB, Collette HJ (1997) Estimation of reproducibility and relative validity of the questions included in the EPIC Physical Activity Questionnaire. Int J Epidemiol 26(Suppl 1):S181-S189
64. InterAct Consortium (2012) Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol 27:15-25